Literature DB >> 28319589

Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.

Bradley A Wall1, Daniel A GALVãO, Naeem Fatehee, Dennis R Taaffe, Nigel Spry, David Joseph, Jeffrey J Hebert, Robert U Newton.   

Abstract

INTRODUCTION: Prostate cancer is the most common cancer in men, and patients treated with androgen deprivation therapy (ADT) experience unfavorable changes in body composition and associated metabolic complications, which can increase the risk of cardiovascular disease. We examined the effect of a 6-month program of aerobic and resistance exercise aimed at improving body composition and cardiorespiratory health in this population.
METHODS: Ninety-seven men (43-90 yr) with localized prostate cancer receiving ADT were randomized to either exercise (EX, n = 50) or usual care (CON, n = 47). Supervised exercise was undertaken twice weekly at moderate to high intensity. Measures of cardiorespiratory capacity (V˙O2max), resting metabolic rate, central blood pressure, hemodynamic variables, blood markers, and body composition were assessed.
RESULTS: There was a significant group-time interaction present for V˙O2max (P = 0.033) with a treatment effect for EX of 0.11 L·min (95% confidence interval [CI] = 0.04-0.19) (relative to body mass = 1.3 mL·kg·min, 95% CI = 0.3-2.3) and fat oxidation (P = 0.037) of 12.0 mg·min (95% CI = 2.3-21.7). Similarly, there was a significant improvement in glucose (P < 0.001) for EX of -0.5 mmol·L (95% CI = -0.8 to -0.3), with no change in prostate-specific antigen or testosterone as a result of exercise. Body composition was enhanced for EX with adjusted mean differences in lean mass (P = 0.015) of 0.8 kg (95% CI = 0.3-1.3), total fat mass (P = 0.020) of -1.1 kg (95% CI = -1.8 to -0.5), and trunk fat mass (P < 0.001) of -1.0 kg (95% CI = -1.4 to -0.6).
CONCLUSION: A 6-month combined aerobic and resistance exercise program has a significant favorable effect on cardiorespiratory capacity, resting fat oxidation, glucose, and body composition despite the adverse effects of hormone suppression. Combined aerobic and resistance training should be considered a key adjuvant component in men undergoing ADT for the treatment of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319589     DOI: 10.1249/MSS.0000000000001277

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  15 in total

Review 1.  The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.

Authors:  Ashley Bigaran; Eva Zopf; Jason Gardner; Andre La Gerche; Declan G Murphy; Erin J Howden; Michael K Baker; Prue Cormie
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-28       Impact factor: 5.554

2.  Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jessica M Scott; Emily C Zabor; Emily Schwitzer; Graeme J Koelwyn; Scott C Adams; Tormod S Nilsen; Chaya S Moskowitz; Konstantina Matsoukas; Neil M Iyengar; Chau T Dang; Lee W Jones
Journal:  J Clin Oncol       Date:  2018-06-12       Impact factor: 44.544

Review 3.  Plausible conditions and mechanisms for increasing physical activity behavior in men with prostate cancer using patient education interventions: sequential explanatory mixed studies synthesis.

Authors:  Elochukwu Fortune Ezenwankwo; Portia Motsoeneng; Elizabeth Maria Atterbury; Yumna Albertus; Estelle Victoria Lambert; Delva Shamley
Journal:  Support Care Cancer       Date:  2022-01-21       Impact factor: 3.603

4.  Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy.

Authors:  Thomas Chaillou; Ashley McPeek; Johanna T Lanner
Journal:  Physiol Rep       Date:  2017-06

5.  Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases.

Authors:  Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Prue Cormie; David Joseph; Suzanne K Chambers; Raphael Chee; Carolyn J Peddle-McIntyre; Nicolas H Hart; Freerk T Baumann; James Denham; Michael Baker; Robert U Newton
Journal:  Med Sci Sports Exerc       Date:  2018-03       Impact factor: 5.411

6.  Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study.

Authors:  Agnieszka Lemanska; Karen Poole; Bruce A Griffin; Ralph Manders; John M Saxton; Lauren Turner; Joe Wainwright; Sara Faithfull
Journal:  BMJ Open       Date:  2019-06-11       Impact factor: 2.692

7.  Optimising weight-loss interventions in cancer patients-A systematic review and network meta-analysis.

Authors:  Nathalie LeVasseur; Wei Cheng; Sasha Mazzarello; Mark Clemons; Lisa Vandermeer; Lee Jones; Anil Abraham Joy; Pauline Barbeau; Dianna Wolfe; Nadera Ahmadzai; Mona Hersi; Carol Stober; Risa Shorr; John Hilton; Brian Hutton
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

8.  Feasibility of an intervention for men on androgen deprivation therapy: A research protocol.

Authors:  Alana Manson; Jamie Myers; Sandra Billinger; Jaimie Ward; William Parker; Jill Hamilton-Reeves; Carrie Michel; Sally L Maliski
Journal:  Res Nurs Health       Date:  2019-08-07       Impact factor: 2.228

Review 9.  Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review.

Authors:  Rebekah L Wilson; Dennis R Taaffe; Robert U Newton; Nicolas H Hart; Philippa Lyons-Wall; Daniel A Galvão
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

10.  Resistance Exercise Dosage in Men with Prostate Cancer: Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Pedro Lopez; Dennis R Taaffe; Robert U Newton; Daniel A Galvão
Journal:  Med Sci Sports Exerc       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.